F. Maignen
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 2
-
- Acute Lymphoblastic Leukemia research 3
- Health and Medical Research Impacts 2
- Co-authors
- Manfred Hauben (5 shared papers)Jim Slattery (1 shared paper)Yolanda Álvarez (1 shared paper)Bernarda Zamora (2 shared papers)Jorge Mestre‐Ferrandiz (2 shared papers)P. O’Neill (2 shared papers)Martina Garau (2 shared papers)Jean‐Michel Dogné (3 shared papers)
- Journals
- Value in Health (3 papers)Pharmacoepidemiology and Drug Safety (2 papers)Drug Safety (2 papers)Therapeutic Advances in Drug Safety (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
F. Maignen
23 papers receiving 290 citations
Peers
Comparison fields: 5 of 59
- Toxicology 107
- Economics and Econometrics 88
- Medical Laboratory Technology 3
- Pediatrics, Perinatology and Child Health 26
- Pharmacology 23
Countries citing papers authored by F. Maignen
This map shows the geographic impact of F. Maignen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Maignen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Maignen more than expected).
Fields of papers citing papers by F. Maignen
This network shows the impact of papers produced by F. Maignen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Maignen. The network helps show where F. Maignen may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Maignen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2010 | 64 | |
| 3 | 2013 | 40 | |
| 4 | 2013 | 20 | |
| 5 | 2020 | 17 | |
| 6 | 2017 | 13 | |
| 7 | 2010 | 12 | |
| 8 | 2018 | 10 | |
| 9 | [Drug-induced aseptic meningitis]. | 1993 | 8 |
| 10 | 2016 | 6 | |
| 11 | [Acute methotrexate poisoning: apropos of 16 cases reported to the Paris Poison Control Center and review of the literature]. | 1997 | 6 |
| 12 | 1996 | 5 | |
| 13 | 2009 | 5 | |
| 14 | 2012 | 5 | |
| 15 | 2017 | 5 | |
| 16 | 2014 | 5 | |
| 17 | 2017 | 3 | |
| 18 | 2020 | 3 | |
| 19 | [Acute toxicity of zidovudine. Analysis of the literature and number of cases at the Paris Poison Control Center]. | 1993 | 3 |
| 20 | 2008 | 2 |
About F. Maignen
F. Maignen is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Toxicology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 304 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers), Acute Lymphoblastic Leukemia research (3 papers), Corneal Surgery and Treatments (2 papers), Health and Medical Research Impacts (2 papers), Glaucoma and retinal disorders (2 papers), Pharmaceutical Economics and Policy (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Toxicology (107 citations), Economics and Econometrics (88 citations), Medical Laboratory Technology (3 citations), Pediatrics, Perinatology and Child Health (26 citations) and Pharmacology (23 citations). F. Maignen has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Manfred Hauben, Jim Slattery, Yolanda Álvarez, Bernarda Zamora, Jorge Mestre‐Ferrandiz, P. O’Neill, Martina Garau, Jean‐Michel Dogné, Eric Hung and Lionel Van Holle. Their work appears in journals such as Value in Health, Pharmacoepidemiology and Drug Safety, Drug Safety, Therapeutic Advances in Drug Safety and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.